MediWound director Form 3 shows option holdings

MediWound Ltd. director Samuel Rubinstein filed an initial Form 3 reporting his equity holdings in the company.

Rhea-AI Filing Summary

MediWound Ltd. director Samuel Rubinstein filed an initial Form 3 reporting his equity holdings in the company. He holds stock options over 7,200, 7,542, 5,600 and 6,250 ordinary shares at exercise prices of $9.6400, $12.7290, $18.5400 and $17.6000, expiring between 2033 and 2036. He also holds 2,843 and 750 ordinary shares directly, plus 525 ordinary shares held indirectly by his spouse. Footnotes state that certain ordinary shares are underlying RSUs granted on March 4, 2026, and certain options were also granted on that date, with each grant vesting 100% on the one-year anniversary of the grant date.

Insider Trade Summary

7 transactions reported

Mixed 7 txns

Insider Rubinstein Samuel

Role Director

Type	Security	Shares	Price	Value
holding	Stock Option (right to buy ordinary shares)	--	--	--
holding	Stock Option (right to buy ordinary shares)	--	--	--
holding	Stock Option (right to buy ordinary shares)	--	--	--
holding	Stock Option (right to buy ordinary shares)	--	--	--
holding	Ordinary shares	--	--	--
holding	Ordinary shares	--	--	--
holding	Ordinary shares	--	--	--

Holdings After Transaction: Stock Option (right to buy ordinary shares) — 26,592 contracts (Direct); Ordinary shares — 3,593 shares (Direct); Ordinary shares — 525 shares (Indirect, By spouse)

Footnotes (2)

1. F1. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
2. F2. The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MediWound (MDWD) Form 3 by Samuel Rubinstein report?

The Form 3 reports Rubinstein’s initial ownership in MediWound. It details his stock options over multiple ordinary share blocks, direct ordinary share holdings, and additional shares held indirectly through his spouse, establishing his baseline equity position as a company director.

What stock options does Samuel Rubinstein hold in MediWound (MDWD)?

Rubinstein holds options to buy ordinary shares at exercise prices of $9.6400, $12.7290, $18.5400 and $17.6000. These option grants cover blocks of 7,200, 7,542, 5,600 and 6,250 underlying ordinary shares and expire between 2033 and 2036.

What ordinary share holdings does Rubinstein report in MediWound (MDWD)?

He reports 2,843 ordinary shares and 750 ordinary shares held directly, plus 525 ordinary shares held indirectly through his spouse. These figures show both his personal ownership and additional family-related holdings in MediWound’s ordinary shares as of the Form 3 filing.

How are RSUs and option vesting described in the MediWound (MDWD) Form 3?

Footnotes explain that certain ordinary shares are underlying RSUs granted on March 4, 2026, vesting 100% one year after that date. Other options granted on the same day also vest 100% on the one-year anniversary, indicating a cliff-vesting structure for these equity awards.

Does the MediWound (MDWD) Form 3 show any insider buying or selling activity?

The Form 3 records holdings rather than transactions, so it does not show buys or sells. All entries are reported as positions in stock options, ordinary shares, and indirect holdings, establishing Rubinstein’s initial ownership status as a director at the reporting date.

What are the expiration dates for Rubinstein’s MediWound (MDWD) stock options?

His reported option grants expire on August 15, 2033, February 26, 2034, February 11, 2035, and March 4, 2036. These long-dated expirations indicate multi-year potential exercise windows tied to MediWound’s ordinary shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 05:23 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Rubinstein Samuel

(Last) (First) (Middle)

C/O MEDIWOUND LTD.

42 HAYARKON STREET

(Street)

YAVNE 8122745

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
MediWound Ltd. [ MDWD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares	2,843	D
Ordinary shares(1)	750	D
Ordinary shares	525	I	By spouse

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy ordinary shares)	08/15/2024	08/15/2033	Ordinary shares	7,200	$9.64	D
Stock Option (right to buy ordinary shares)	02/26/2025	02/26/2034	Ordinary shares	7,542	$12.729	D
Stock Option (right to buy ordinary shares)	02/11/2026	02/11/2035	Ordinary shares	5,600	$18.54	D
Stock Option (right to buy ordinary shares)	(2)	03/04/2036	Ordinary shares	6,250	$17.6	D

Explanation of Responses:

1. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.

2. The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.

	/s/ Yaron Meyer, attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)